-
Significance of confirming Epstein-Barr virus nuclear antibody as tumor markerStošić-Divjak, Svetlana ...Study of the association between Epstein-Barr virus (EBV) and the tumors of the nasopharynx renders an opportunity to introduce causal treatment Already have been proven the anti-EBV ... (anti-Epstein-Barr nucleus antigene) antibodies in the blood serum of the patients infected with EBV, while over 91% of the patients with nasopharyngeal malignant tumors also have a detectable anti-EBV marker. The aim of this research was to determine if there were anti-EBV antibodies in the serum of the patients with the already verified nasopharyngeal malignant tumors, and, if there were, to determine the quantitative ratio to the values in the serum of the healthy controls. METHODS: The study involved 74 individuals in the period from 1994-2001 divided into four groups: group A counting 11 patients with undifferentiated carcinome of nasopharyngeal type (UCNT); group B counting 25 patients with UCNT X-ray treated at least three years before the onset of the study; group Cincluding 28 healthy subjecets (blood donors), and the group D with 10 patients with planocellular nasopharyngeal carcinoma. Serologic diagnostics ofthe patients serum was performed using the techniques of Reedman and Klein for the detection of anti-EBV antibodies in the serum. RESULTS: The presence of the statistically significantly higher values of the mean geometric titer (MGT) of the anti-EBNA antibodies was determined in 36 patients with histologically verified UCNT as compared with the control groups including 10 patients with planocellular carcinomas of the nasopharynx and 28 blood donors.Presented were anti-EBNA titers with 95% confidence interval for any participants according to the Hoo clinical classification of nasopharyngeal tumors, as well as according to the fact if they had been radiotreated within the previous three years. CONCLUSION: The results of this study confirm the conclusions of the recent literature on the possible etiopathogenesis of nasopharyngeal tumors and the use of viral anti-EBNA antibodies as viral markers in the diagnostics of UCNT diseases.Vir: Vojnosanitetski pregled : časopis lekara i farmaceuta Jugoslovenske narodne armije = Military-medical and pharmaceutical review of the Yugoslav people's army = Žurnal vračej i farmacevtov Jugoslavskoj narodnoj armii. - ISSN 0042-8450 (Vol. 64, br. 7, 2007, str. 459-462)Vrsta gradiva - članek, sestavni del ; uLeto - 2007Jezik - srbskiCOBISS.SI-ID - 60080129
Avtor
Stošić-Divjak, Svetlana |
Đukić, Vojko, 1955- |
Boricić, I. |
Racić, AJ |
Divjak, I. |
Krsmanović, Velibor
Teme
bolezni dihal |
otorinolaringologija |
nosna votlina |
požiralnik |
nasofarinks |
imunologija |
antitelesa |
biokemija |
molekularna biologija |
antigeni |
virusni markerji |
onkologija |
rak |
karcinom |
tumorski markerji
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Stošić-Divjak, Svetlana | 91096 |
Đukić, Vojko, 1955- | ![]() |
Boricić, I. | ![]() |
Racić, AJ | ![]() |
Divjak, I. | ![]() |
Krsmanović, Velibor | ![]() |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.